RedGDPS
@redgdps.bsky.social
Fundación de la Red de Grupos de Estudio de la Diabetes en Atención Primaria. Comprometidos con la #diabetes.
" Ponle luz a la Diabetes", 4° #CongresoRedGDPS, 27-28 Noviembre en Valencia
www.redgdps.org
" Ponle luz a la Diabetes", 4° #CongresoRedGDPS, 27-28 Noviembre en Valencia
www.redgdps.org
Acceso en @PubMedOnline
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
https://pubmed.ncbi.nlm.nih.gov/40876474/
t.co
December 11, 2025 at 4:41 PM
Acceso en @PubMedOnline
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
Full text links
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
OBJECTIVE. To assess the real-world frequency and characteristics associated with type 2 diabetes remission in a large and diverse cohort of U.S. adults.RE
diabetesjournals.org
December 4, 2025 at 4:39 PM
Full text links
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Acceso en @PubMedOnline
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
December 4, 2025 at 4:39 PM
Acceso en @PubMedOnline
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
🚀 Si trabajas con evidencia científica o simplemente quieres comprender mejor lo que lees, #Mati te va a ahorrar horas y a mejorar la calidad de tus decisiones
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
November 23, 2025 at 5:29 PM
🚀 Si trabajas con evidencia científica o simplemente quieres comprender mejor lo que lees, #Mati te va a ahorrar horas y a mejorar la calidad de tus decisiones
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
📊🤓Además, añade un “Comentario de Mati” donde valora la calidad y relevancia real del estudio:
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
November 23, 2025 at 5:29 PM
📊🤓Además, añade un “Comentario de Mati” donde valora la calidad y relevancia real del estudio:
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
Así nos lo explica #CarlosHndezTeixido en este 🧵 👇🏼
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
November 23, 2025 at 5:29 PM
Así nos lo explica #CarlosHndezTeixido en este 🧵 👇🏼
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
Full text links
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled T...
Background: Limited research has been done to evaluate the combined effect of energy reduction, Mediterranean diet (MedDiet), and physical activity on type 2 diabetes incidence. Objective: To evaluate...
www.acpjournals.org
November 20, 2025 at 9:32 PM
Full text links
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Acceso en @PubMedOnline
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
https://pubmed.ncbi.nlm.nih.gov/40854218/
t.co
November 20, 2025 at 9:32 PM
Acceso en @PubMedOnline
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
Acceso en @PubMedOnline
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 American Diabetes Association "Standards of Care in Diabetes" - PubMed
The American Diabetes Association (ADA) publishes the "Standards of Care in Diabetes" (SOC) annually to offer clinicians, patients, and payers evidence-based guidelines for diabetes management. The 2025 SOC recommends that clinicians consider screening asymptomatic adults with diabetes for heart fai …
pubmed.ncbi.nlm.nih.gov
November 16, 2025 at 4:10 PM
Acceso en @PubMedOnline
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/
Full text links
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al
the PRECOZIN Study Group
pmc.ncbi.nlm.nih.gov/articles/PMC12…
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al
the PRECOZIN Study Group
pmc.ncbi.nlm.nih.gov/articles/PMC12…
https://pmc.ncbi.nlm.nih.gov/articles/PMC12…
November 6, 2025 at 9:24 PM
Full text links
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al
the PRECOZIN Study Group
pmc.ncbi.nlm.nih.gov/articles/PMC12…
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al
the PRECOZIN Study Group
pmc.ncbi.nlm.nih.gov/articles/PMC12…
Acceso Bibliografia @PubMedOnline
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al. BMJ Open. 2025.
pubmed.ncbi.nlm.nih.gov/40983582/
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al. BMJ Open. 2025.
pubmed.ncbi.nlm.nih.gov/40983582/
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study - PubMed
Antidiabetic medication prescribing at the diagnosis of T2DM was high. Most prescriptions contained metformin. Monotherapy decreased in 2023-2024 compared with 2018-2022, while combination therapy increased due to increased prescriptions of metformin with SGLT2i and/or GLP1a.
pubmed.ncbi.nlm.nih.gov
November 6, 2025 at 9:24 PM
Acceso Bibliografia @PubMedOnline
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al. BMJ Open. 2025.
pubmed.ncbi.nlm.nih.gov/40983582/
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucia Cea-Soriano et al. BMJ Open. 2025.
pubmed.ncbi.nlm.nih.gov/40983582/